Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-08

Clinical Trial Update: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease [Phase 3]

View source ↗

Summary

This update reports completion of a Phase 3 trial evaluating baclofen for alcohol dependence, with or without alcoholic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

Sponsor: South West Sydney Local Health District | Conditions: Alcoholic Liver Disease, Alcohol Dependence | Phase 3 | Status: COMPLETED